Crossmark

Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agents

Crossref DOI link: https://doi.org/10.1016/j.aohep.2022.100751

Published Print: 2023-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

García-Compeán, Diego

Kumar, Ramesh

Cueto-Aguilera, Ángel Noe del

Maldonado-Garza, Héctor Jesús

Villarreal-Pérez, Jesús Zacarías
License Information

Text and Data Mining valid from 2023-07-01

Text and Data Mining valid from 2023-07-01

Version of Record valid from 2022-08-16
More Information

This article is maintained by: Elsevier

Article Title: Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agents

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2022.100751

Content Type: article

Copyright: © 2022 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.